Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MAVRTX · Entity 2875 | SVP and Catalyst | May 18, 2009 | May 19, 2009 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VERTEX PHARMACEUTICALS INC / MA
Report date May 18, 2009 · Filed May 19, 2009
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,473 |
Reported balance
After 2009-05-18 transaction · row 1
1 source rowRow 1 · 2009-05-18 · Sale · Disposed 532 · Balance 37,473 F1: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. F2: Open market sales reported on this line occurred at a weighted average price of $28.45 (range $28.12 to $28.95). F3: Mr. Garrison undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| Common StockSEC Table I · non-derivative | Indirect401(k) | 1,309 |
Reported balance
Holding disclosure · report date 2009-05-18 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,309 |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1.
F2: Open market sales reported on this line occurred at a weighted average price of $28.45 (range $28.12 to $28.95).
F3: Mr. Garrison undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 18, 2009 Filed May 19, 2009 18:21 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 532 | $28.45 | $15,135.40 |
DisclosureSEC source: 0000875320-09-000031 · edgar.xml · nonDerivative · entry 1 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,473 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. F2 · kind: Open market sales reported on this line occurred at a weighted average price of $28.45 (range $28.12 to $28.95). F2 · price: Open market sales reported on this line occurred at a weighted average price of $28.45 (range $28.12 to $28.95). F3 · price: Mr. Garrison undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 05, 2009 Filed Feb 6, 2009 21:23 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 45,750 | $0.00 Strike: $33.55 | $0.00 |
DisclosureSEC source: 0000875320-09-000008 · edgar.xml · derivative · entry 3 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,750 Underlying: Common Stock · 45,750 shares Expires 2019-02-04 F2 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/05/09. Read SEC document |
| February 05, 2009 Filed Feb 6, 2009 21:23 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantCommon Stock | 10,166 | $0.01 | $101.66 |
DisclosureSEC source: 0000875320-09-000008 · edgar.xml · nonDerivative · entry 1 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,437 F1 · shares: Stock grant made under 2006 Stock and Option Plan, vesting on 2/5/2013, subject to 50% acceleration upon filing a new drug application with the FDA for telaprevir and 50% acceleration upon the approval of a new drug application for telaprevir. Read SEC document |
| December 15, 2008 Filed Dec 16, 2008 18:23 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 1,595 | $25.24 | $40,257.80 |
DisclosureSEC source: 0000875320-08-000095 · edgar.xml · nonDerivative · entry 2 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,307 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $25.24 (range $25.04 to $25.81). F4 · price: Mr. Garrison undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| December 15, 2008 Filed Dec 16, 2008 18:23 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 380 | $24.80 | $9,424.00 |
DisclosureSEC source: 0000875320-08-000095 · edgar.xml · nonDerivative · entry 1 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,902 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $24.80 (range $24.79 to $24.80). F4 · price: Mr. Garrison undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 18, 2008 Filed Nov 19, 2008 21:24 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 86 | $26.12 | $2,246.32 |
DisclosureSEC source: 0000875320-08-000087 · edgar.xml · nonDerivative · entry 1 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,282 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a wieghted average price of $26.12 (range $25.70 to $26.53). F3 · price: Mr. Garrison undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| July 24, 2008 Filed Jul 25, 2008 15:11 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Options · Derivative | 30,500 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0000875320-08-000058 · edgar.xml · derivative · entry 1 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,500 Underlying: Common Stock · 30,500 shares Expires 2018-07-23 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008. Read SEC document |
| May 20, 2008 Filed May 22, 2008 13:28 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 73 | $27.94 | $2,039.62 |
DisclosureSEC source: 0000875320-08-000030 · edgar.xml · nonDerivative · entry 9 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,282 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 20, 2008 Filed May 22, 2008 13:28 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 72 | $27.68 | $1,992.96 |
DisclosureSEC source: 0000875320-08-000030 · edgar.xml · nonDerivative · entry 8 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,355 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 20, 2008 Filed May 22, 2008 13:28 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 72 | $27.64 | $1,990.08 |
DisclosureSEC source: 0000875320-08-000030 · edgar.xml · nonDerivative · entry 7 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,427 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 20, 2008 Filed May 22, 2008 13:28 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 72 | $27.54 | $1,982.88 |
DisclosureSEC source: 0000875320-08-000030 · edgar.xml · nonDerivative · entry 6 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,499 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 20, 2008 Filed May 22, 2008 13:28 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 73 | $27.47 | $2,005.31 |
DisclosureSEC source: 0000875320-08-000030 · edgar.xml · nonDerivative · entry 5 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,571 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 20, 2008 Filed May 22, 2008 13:28 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 73 | $27.71 | $2,022.83 |
DisclosureSEC source: 0000875320-08-000030 · edgar.xml · nonDerivative · entry 4 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,644 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 20, 2008 Filed May 22, 2008 13:28 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 146 | $27.61 | $4,031.06 |
DisclosureSEC source: 0000875320-08-000030 · edgar.xml · nonDerivative · entry 3 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,717 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 20, 2008 Filed May 22, 2008 13:28 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 72 | $27.59 | $1,986.48 |
DisclosureSEC source: 0000875320-08-000030 · edgar.xml · nonDerivative · entry 2 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,863 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 20, 2008 Filed May 22, 2008 13:28 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 74 | $27.48 | $2,033.52 |
DisclosureSEC source: 0000875320-08-000030 · edgar.xml · nonDerivative · entry 1 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,935 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:12 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 258 | $27.70 | $7,146.60 |
DisclosureSEC source: 0000875320-08-000024 · edgar.xml · nonDerivative · entry 10 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,282 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:12 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 200 | $27.46 | $5,492.00 |
DisclosureSEC source: 0000875320-08-000024 · edgar.xml · nonDerivative · entry 9 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,540 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:12 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 200 | $27.27 | $5,454.00 |
DisclosureSEC source: 0000875320-08-000024 · edgar.xml · nonDerivative · entry 8 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,740 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:12 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 200 | $27.20 | $5,440.00 |
DisclosureSEC source: 0000875320-08-000024 · edgar.xml · nonDerivative · entry 7 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,940 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:12 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 200 | $27.13 | $5,426.00 |
DisclosureSEC source: 0000875320-08-000024 · edgar.xml · nonDerivative · entry 6 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,140 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:12 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 200 | $27.08 | $5,416.00 |
DisclosureSEC source: 0000875320-08-000024 · edgar.xml · nonDerivative · entry 5 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,340 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:12 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 300 | $27.07 | $8,121.00 |
DisclosureSEC source: 0000875320-08-000024 · edgar.xml · nonDerivative · entry 4 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,540 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:12 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 300 | $27.03 | $8,109.00 |
DisclosureSEC source: 0000875320-08-000024 · edgar.xml · nonDerivative · entry 3 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,840 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:12 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 200 | $27.00 | $5,400.00 |
DisclosureSEC source: 0000875320-08-000024 · edgar.xml · nonDerivative · entry 2 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,140 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:12 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 200 | $26.99 | $5,398.00 |
DisclosureSEC source: 0000875320-08-000024 · edgar.xml · nonDerivative · entry 1 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,340 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| February 07, 2008 Filed Feb 11, 2008 20:54 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 45,750 | $0.00 Strike: $18.93 | $0.00 |
DisclosureSEC source: 0000875320-08-000008 · edgar.xml · derivative · entry 3 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,750 Underlying: Common Stock · 45,750 shares Expires 2018-02-06 F2 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 02/07/2008, subject to shareholder approval. Read SEC document |
| February 07, 2008 Filed Feb 11, 2008 20:54 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantCommon Stock | 10,166 | $0.01 | $101.66 |
DisclosureSEC source: 0000875320-08-000008 · edgar.xml · nonDerivative · entry 1 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,540 F1 · shares: Stock grant made under 2006 Stock and Option Plan, vesting on 2/7/2012, subject to acceleration upon achievement of certain performance-based milestones. Read SEC document |
| November 16, 2007 Filed Nov 19, 2007 19:54 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 63 | $26.16 | $1,648.08 |
DisclosureSEC source: 0000875320-07-000111 · edgar.xml · nonDerivative · entry 9 GARRISON RICHARD C · CIK 0001256466 · SVP, Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,374 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| November 16, 2007 Filed Nov 19, 2007 19:54 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 63 | $26.10 | $1,644.30 |
DisclosureSEC source: 0000875320-07-000111 · edgar.xml · nonDerivative · entry 8 GARRISON RICHARD C · CIK 0001256466 · SVP, Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,437 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| November 16, 2007 Filed Nov 19, 2007 19:54 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 63 | $26.05 | $1,641.15 |
DisclosureSEC source: 0000875320-07-000111 · edgar.xml · nonDerivative · entry 7 GARRISON RICHARD C · CIK 0001256466 · SVP, Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,500 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| November 16, 2007 Filed Nov 19, 2007 19:54 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 62 | $25.97 | $1,610.14 |
DisclosureSEC source: 0000875320-07-000111 · edgar.xml · nonDerivative · entry 6 GARRISON RICHARD C · CIK 0001256466 · SVP, Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,563 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| November 16, 2007 Filed Nov 19, 2007 19:54 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 63 | $25.96 | $1,635.48 |
DisclosureSEC source: 0000875320-07-000111 · edgar.xml · nonDerivative · entry 5 GARRISON RICHARD C · CIK 0001256466 · SVP, Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,625 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| November 16, 2007 Filed Nov 19, 2007 19:54 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 63 | $25.95 | $1,634.85 |
DisclosureSEC source: 0000875320-07-000111 · edgar.xml · nonDerivative · entry 4 GARRISON RICHARD C · CIK 0001256466 · SVP, Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,688 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| November 16, 2007 Filed Nov 19, 2007 19:54 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 62 | $25.93 | $1,607.66 |
DisclosureSEC source: 0000875320-07-000111 · edgar.xml · nonDerivative · entry 3 GARRISON RICHARD C · CIK 0001256466 · SVP, Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,751 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| November 16, 2007 Filed Nov 19, 2007 19:54 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 126 | $25.83 | $3,254.58 |
DisclosureSEC source: 0000875320-07-000111 · edgar.xml · nonDerivative · entry 2 GARRISON RICHARD C · CIK 0001256466 · SVP, Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,813 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| November 16, 2007 Filed Nov 19, 2007 19:54 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 62 | $25.82 | $1,600.84 |
DisclosureSEC source: 0000875320-07-000111 · edgar.xml · nonDerivative · entry 1 GARRISON RICHARD C · CIK 0001256466 · SVP, Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,939 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| July 12, 2007 Filed Jul 16, 2007 18:13 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 30,500 | $0.00 Strike: $28.84 | $0.00 |
DisclosureSEC source: 0000875320-07-000080 · edgar.xml · derivative · entry 1 GARRISON RICHARD C · CIK 0001256466 · SVP, Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,500 Underlying: Common Stock · 30,500 shares Expires 2017-07-11 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/12/2007. Read SEC document |
| May 17, 2007 Filed May 21, 2007 19:18 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 632 | $31.95 | $20,192.40 |
DisclosureSEC source: 0000875320-07-000050 · edgar.xml · nonDerivative · entry 1 GARRISON RICHARD C · CIK 0001256466 · SVP, Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,374 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| January 24, 2007 Filed Jan 26, 2007 20:47 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 45,750 | $0.00 Strike: $36.30 | $0.00 |
DisclosureSEC source: 0000875320-07-000017 · edgar.xml · derivative · entry 3 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,750 Underlying: Common Stock · 45,750 shares Expires 2017-01-23 F2 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 01/24/2007. Read SEC document |
| January 24, 2007 Filed Jan 26, 2007 20:47 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantCommon Stock | 10,166 | $0.01 | $101.66 |
DisclosureSEC source: 0000875320-07-000017 · edgar.xml · nonDerivative · entry 1 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,374 F1 · shares: Stock grant made under 2006 Stock and Option Plan, vesting on 1/24/2011, subject to acceleration upon achievement of certain performance-based milestones. Read SEC document |
| December 22, 2006 Filed Dec 27, 2006 18:53 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 1,975 | $37.56 | $74,181.00 |
DisclosureSEC source: 0000875320-06-000125 · edgar.xml · nonDerivative · entry 1 GARRISON RICHARD C · CIK 0001256466 · SVP, Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,208 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| July 20, 2006 Filed Jul 24, 2006 17:54 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 30,500 | $0.00 Strike: $35.35 | $0.00 |
DisclosureSEC source: 0000875320-06-000068 · edgar.xml · derivative · entry 1 GARRISON RICHARD C · CIK 0001256466 · SVP, Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,500 Underlying: Common Stock · 30,500 shares Expires 2016-07-19 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/20/2006. Read SEC document |
| February 02, 2006 Filed Feb 6, 2006 21:49 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 30,000 | $0.00 Strike: $35.64 | $0.00 |
DisclosureSEC source: 0000875320-06-000016 · edgar.xml · derivative · entry 2 GARRISON RICHARD C · CIK 0001256466 · SVP, Organizational Developmen 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,000 Underlying: Common Stock · 30,000 shares Expires 2016-02-01 F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 02/02/2006. Read SEC document |
| February 02, 2006 Filed Feb 6, 2006 21:49 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantCommon Stock | 5,000 | $0.01 | $50.00 |
DisclosureSEC source: 0000875320-06-000016 · edgar.xml · nonDerivative · entry 1 GARRISON RICHARD C · CIK 0001256466 · SVP, Organizational Developmen 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,900 F1 · shares: Stock grant made under 1996 Stock and Option Plan, vesting on 2/2/2010, subject to acceleration upon achievement of certain performance-based milestones. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.